EPIPEN

This brand name is authorized in United States. It is also authorized in Australia, Austria, Canada, Croatia, Estonia, Finland, France, Ireland, Israel, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, UK.

Active ingredients

The drug EPIPEN contains one active pharmaceutical ingredient (API):

1	Adrenaline UNII YKH834O4BH - EPINEPHRINE
	Epinephrine is a direct acting sympathomimetic agent, which exerts effects on both α and β adrenoceptors. It has more pronounced effects on β than on α adrenoceptors, although α effects prevail at high doses. The effects of adrenaline include increased rate and force of cardiac contraction, cutaneous vasoconstriction and broncho-dilatation.
	Read more about Epinephrine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EPIPEN Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C01CA24	Epinephrine	C Cardiovascular system → C01 Cardiac therapy → C01C Cardiac stimulants excl. cardiac glycosides → C01CA Adrenergic and dopaminergic agents
Discover more medicines within C01CA24

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8697R, 8698T
CA	Health Products and Food Branch	00509558, 00578657
EE	Ravimiamet	1124930, 1124941, 1529658, 1529669, 1531033, 1588844, 1588855, 1588866, 1588877
FI	Lääkealan turvallisuus- ja kehittämiskeskus	178945, 182343, 556156, 564373
FR	Base de données publique des médicaments	61846627, 68293517
GB	Medicines & Healthcare Products Regulatory Agency	46867, 47195, 91650, 91652
HR	Agencija za lijekove i medicinske proizvode	HR-H-299251328, HR-H-987056369
IE	Health Products Regulatory Authority	15920, 15928, 15943, 15951
IL	מִשְׂרַד הַבְּרִיאוּת	1322, 1323, 7547, 7653
JP	医薬品医療機器総合機構	2451402G2020, 2451402G3026
LT	Valstybinė vaistų kontrolės tarnyba	1066890, 1066891, 1071715, 1071716
MT	Medicines Authority	AA770/02603, AA770/02604
NL	Z-Index G-Standaard	13780190, 13780212
NL	Z-Index G-Standaard, PRK	145262, 145289
NZ	Medicines and Medical Devices Safety Authority	7681, 7682
PL	Rejestru Produktów Leczniczych	100162478, 100261192
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W68719001, W68719002, W68720001, W68720002
SG	Health Sciences Authority	13288P, 13290P
US	FDA, National Drug Code	49502-500, 49502-501
ZA	Health Products Regulatory Authority	27/5.1/0063, 38/5.1/0278